跳至主要内容

Discovery Biology Services


Our structural biology department offers services supporting structure-based drug discovery from determination of novel targets to final structures. Our platform is one of the earliest established structural biology platform in China and has been certified by the Shanghai government.

Enzymatic-Based Assay


Multiple Technology Platforms

  • Lance Assay
  • Alphascreen Assay
  • Z’-LYTE Assay
  • Adapta Assay
  • Kinase-Glo Assay
  • ADP-Glo Assay
  • Ligand Binding
  • ELISA Assay
  • HTRF Assay

Diversified Targets and Applications

  • Kinases
  • GPCR
  • Proteases
  • Transcription Factors
  • Cytokines
  • Metabolic Enzymes
  • Biomarker
  • Protein Binding
  • Protein Interacting
  • Compound screening

Cell-Based Assay

  • Cytotoxicity Assay
  • Apoptosis Assay
  • Cell Migration Assay
  • Cell Invasion Assay
  • HTRF Cell-based Assay
  • Immunostaining Assay
  • Immunofluorescence Assay (96/384 wells)
  • Reporter Gene Assay (GFP/Luc)
  • Radioactive Ligand/receptor Binding Assay
  • Cellular Uptake Assay
  • Gene Knockdown Assay
  • MicroRNA Overexpression Assay
  • MicroRNA Knockdown Assay
  • Adenovirus/Retrovirus/ Lentivirus 
 Medicilon has established over 100 different cancer cell lines for cell-based assays including:

  • Breast cancer cell line
  • Colorectal cancer line
  • Leukemia cell line
  • Liver cancer cell line
  • Kidney cancer cell line
  • Lung cancer cell line
  • Melanoma cell lines
  • Ovarian cell lines
  • Pancreas cell lines
  • Gastric cancer cell lines

Cell Biology & Biochemistry

  • Custom assay development 
  • Compound screening and profiling 
  • SAR study and medicinal chemistry support 
  • Middle-throughput screening 
  • Mechanism-of-action study and biomarker analysis

Radioactive Assay

  • Radioactive receptor binding assay 
  • Radioligand binding assay 
  • Radioactive uptake assay 
  • Cell proliferation assay ( H-TdR) 
  • Radioimmunoassay (RIA)
  • Immunoradiometric assay (IRMA)
Stable Cell Line Generation

Stable Cell Line Generation

  • Overexpression 
  • Knock-out 
  • Cell Lines – Mammalian cell lines

Stable Cell Line Generation-Overexpression/Knock-out

96-well immunoflouresence staining to screen for stable cell lines
PCR to screen for gene knock-out in HCT116 cells (95% positive clones)
M: DL2000 DNA Marker
  1. Clone 1-HA1 (921bp)
  2. Clone 1-HA-2 (1525bp)
  3. Clone 4-HA1 (921bp)
  4. Clone 4-HA-2 (1525bp)
  5. Clone 5-HA1 (921bp)
  6. Clone 5-HA-2 (1525bp)

RNAi & MicroRNA Technologies

Knocking down targeted protein expression in cells transfected with siRNA
Overexpression of microRNA candidates inducing apoptosis in HT29 cells

标签：

评论

发表评论

此博客中的热门博文

What is preclinical testing?

In the process of  preclinical testing  of a compound or biological agent into a drug, the compound involved must go through the testing phase. First, we need to identify potential targets that can treat the disease. Then, a variety of compounds or preparations are screened out. Any compound that has shown potential as a drug for the treatment of this disease needs to be tested for toxicity before clinical testing to reduce the possibility of injury. preclinical testing What is the basis of preclinical testing? According to US Food and Drug Administration (FDA) regulations, a series of tests are required before a new drug is approved for use. In the first stage, basic research determines a hypothetical target for the treatment of a certain disease, and then screens small molecules or biological compounds to discover any substance with the potential to treat the disease. Then, a  preclinical research  phase followed, before which, as described above, the potential toxicity of the compou
发表评论
阅读全文

Inventory of the three major in vitro pharmacokinetic research methods

  The metabolic properties of a compound are an essential factor in whether or not it can be used as a drug in the clinical setting, so pharmacokinetic studies of newly synthesized compounds are required in drug development. In vitro incubation with liver microsomes, recombinant CYP450 enzyme lines, and in vitro incubation with hepatocytes are some of the more common in vitro drug metabolism methods. 1. In vitro incubation method with liver microsomes The metabolic stability and metabolic phenotypes of candidate compounds in different species of liver microsomes are good predictors of the metabolic properties of compounds in vivo. They are practical tools for evaluating candidate compounds in the pre-development phase of drug development. Liver microsomes include rat liver microsomes, human liver microsomes, canine liver microsomes, monkey liver microsomes, and mouse liver microsomes. In in vitro incubation of the liver, microsomes are the "gold standard" for in vitro d
发表评论
阅读全文

Novel Parkinson’s Therapies Possible with New Mouse Model

Parkinson's disease (PD) is a neurodegenerative disorder that is marked by the accumulation of the protein, α-synuclein (αS), into clumps known as Lewy bodies, which diminish neural health. Now, researchers from Brigham and Women's Hospital (BWH) report the development of a mouse model to induce PD-like αS aggregation, leading to resting tremor and abnormal movement control. The mouse responds to L-DOPA, similarly to patients with PD. The team's study (“Abrogating Native α-Synuclein Tetramers in Mice Causes a L-DOPA-Responsive Motor Syndrome Closely Resembling Parkinson’s Disease”) on the use of this transgenic mouse model appears in  Neuron . “α-Synuclein (αS) regulates vesicle exocytosis but forms insoluble deposits in PD. Developing disease-modifying therapies requires animal models that reproduce cardinal features of PD. We recently described a previously unrecognized physiological form of αS, α-helical tetramers, and showed that familial PD-causing missense mutati
发表评论
阅读全文